ArticleOncoTargets and therapy2016

Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer.

Kai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.